Target Market Readiness Ohmx offers a portable, low-cost POC platform capable of quantitative analysis across DNA, proteins, and small molecules from small samples. This positions the company to pursue clinicians and urgent care facilities that need rapid, comprehensive testing at the point of care, enabling upsell opportunities to clinics expanding chronic disease screening and preventive care programs.

Small Team Agility With a lean team and under $1M in revenue, Ohmx is likely receptive to partnerships, OEM relationships, and channel strategies. Potential sales opportunities include collaboration with larger medical device manufacturers for platform integration or with value-based care networks seeking scalable diagnostics with cost advantages.

Funding Leverage Having achieved $9.9M in funding signals investor confidence and growth potential. This can be used to approach multi-site health systems and distributors with a plan for rapid deployment, capital-efficient adoption, and leveraging funding to justify ROIs in hospital networks seeking innovative POC diagnostics.

Cost-Effective Diagnostics The emphasis on low-cost, comprehensive POC testing aligns with health systems aiming to reduce per-test costs and readmission rates. Sales opportunities exist with integrated care programs, preventive medicine initiatives, and telehealth-enabled clinics that require scalable, affordable diagnostic solutions for at-risk populations.

Strategic Differentiation As a platform capable of quantitative analysis across DNA, proteins, and small molecules at the POC, Ohmx can differentiate through bundled offerings (hardware plus consumables and software analytics) and managed services. Target partnerships with large distributors or hospital networks seeking a unique multi-analyte solution can accelerate market entry and patient impact.